Search Results - "Gavras, H."

Sympathetic overactivity in hypertension and cardiovascular disease by Manolis, A J, Poulimenos, L E, Kallistratos, M S, Gavras, I, Gavras, H

“…From the first description of its anatomy by T. Willis to the novel therapeutic manipulations, it is unanimously recognized that the sympathetic nervous system…”
Get more information

Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension by Marketou, M E, Kontaraki, J, Zacharis, E, Parthenakis, F, Maragkoudakis, S, Gavras, I, Gavras, H, Vardas, P E

“…Bradykinin participates in various hypertensive processes, exerted via its type 1 and type 2 receptors (BKR1 and BKR2). The aim of the study was to investigate…”
Get full text

Angiotensin II as a cardiovascular risk factor by GAVRAS, I, GAVRAS, H

“…A renin-angiotensin level that is inappropriately high for the systemic blood pressure and the state of sodium balance is now recognized to be one of the…”
Get full text

Pleiotropic Effects of Statins May Improve Outcomes in Atherosclerotic Renovascular Disease by Silva, Vanessa S., Martin, Luis C., Franco, Roberto J.S., Carvalho, Fabio C., Bregagnollo, Edson A., Castro, Joao H., Gavras, Irene, Gavras, Haralambos

“…Background Atherosclerotic renovascular disease (ARD) coexists with arterial obstructive disease in the coronary, cerebral, and peripheral arteries that may…”
Get full text

Issues in hypertension: drug tolerability and special populations by Gavras, Haralambos P

“…Improvements in the death rate from coronary heart disease and in the control of hypertension have leveled off in recent years, reversing a trend toward steady…”
Get full text

Attenuation of Angiotensin II–Induced Hypertension and Cardiac Hypertrophy in Transgenic Mice Overexpressing a Type 1 Receptor Mutant by Ahmad, Saad, Cesana, Francesca, Lamperti, Edward, Gavras, Haralambos, Yu, Jun

“…Background The angiotensin II (AngII) type 1 receptor (AT1) regulates cardiovascular function by activating various signal pathways. The purpose of this study…”
Get full text

Historical evolution of angiotensin II receptor blockers: therapeutic advantages by Gavras, H

Get full text

Effects of Eprosartan Versus Enalapril in Hypertensive Patients on the Renin-Angiotensin-Aldosterone System and Safety Parameters: Results from a 26-Week, Double-blind, Multicentre Study by Gavras, I., Gavras, H.

“…Summary A double-blind comparator study was performed in 528 hypertensive patients [baseline sitting diastolic blood pressure (SitDBP) 95-114 mmHg]. The…”
Get full text

Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy by Manolis, Athanasios J., Iraklianou, Stella, Pittaras, Andreas, Zairis, Michael, Tsioufis, Konstantinos, Psaltiras, George, Psomali, Demetra, Foussas, Stefanos, Gavras, Irene, Gavras, Haralambos

“…Diabetes mellitus (DM) is known to cause increased arterial wall stiffness and increased cardiovascular risk, even in the absence of hypertension. This study…”
Get full text

Update on the clinical pharmacology of candesartan cilexetil by Gavras, Haralambos

“…The renin-angiotensin system plays a central role in the regulation of blood pressure through its primary effector hormone angiotensin II. Studies conducted…”
Get full text

Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells by Kintsurashvili, E, Duka, I, Gavras, I, Johns, C, Farmakiotis, D, Gavras, H

“…Bradykinin has vasodilatory and tissue-protective effects exerted via its B(2) type receptor, whereas the B(1) receptor is constitutively absent but inducible…”
Get more information

Association between hypervolemia and ventricular hypertrophy in hemodialysis patients by Martin, L.C., Franco, R.J.S., Gavras, I., Matsubara, B.B., Garcia, S., Caramori, J.T., Barretti, B.B., Balbi, A.L., Barsanti, R., Padovani, C., Gavras, H.

“…Left ventricular hypertrophy (LVH) is a well-known predictor of cardiovascular mortality in patients who have end-stage renal disease and are maintained on…”
Get full text

The antiarrhythmic potential of angiotensin II antagonism: experience with losartan by Gavras, Irene, Gavras, Haralambos

“…A large body of literature accumulated over the past several years supports the notion that inhibition of the renin-angiotensin system protects the heart and…”
Get full text

Maternal component in the familial aggregation of hypertension by DeStefano, AL, Gavras, H, Heard-Costa, N, Bursztyn, M, Manolis, A, Farrer, LA, Baldwin, CT, Gavras, I, Schwartz, F

“…To assess maternal versus paternal contributions to the familial aggregation of hypertension, we examined family history data from 344 hypertensive probands…”
Get full text

Genetic predisposition to stroke in relatives of hypertensives by NICOLAOU, M, DESTEFANO, A. L, GAVRAS, I, CUPPLES, L. A, MANOLIS, A. J, BALDWIN, C. T, GAVRAS, H, FARRER, L. A

“…The genetic basis of stroke is poorly understood. We evaluated patterns of familial aggregation of hypertension and stroke to test the hypothesis that…”
Get full text

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981 by Brunner, D B, Desponds, G, Biollaz, J, Keller, I, Ferber, F, Gavras, H, Brunner, H R, Schelling, J L

Get full text

D043 Efficacy of eprosartan in patients with essential hypertension: A 26-week comparison study of eprosartan versus enalapril by Gavras, H., Gavras, I.

Get full text

Oral milrinone in severe chronic heart failure by Gavras, H

Get full text

Cardioprotective potential of angiotensin converting enzyme inhibitors by Gavras, H, Gavras, I

Get more information

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects by Brunner, D.B., Desponds, G., Biollaz, J., Keller, I., Ferber, F., Gavras, H., Brunner, H.R., Schelling, J.L.

Get full text